missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Novus Biologicals™ Recombinant Human IGF-I/IGF-1 LR3 Protein
Recombinant Protein
Marca: Novus Biologicals™ NBP2-61314-5mg
Este artículo no se puede devolver.
Vea la política de devoluciones
Descripción
Assay 1: Fully biologically active when compared to standard. Measured in a serum-free cell proliferation assay using human MCF-7 cells. The ED50 for this effect is 0.3-1.5 ng/mL, corresponding to a specific activity of > 6.7 x 10^5 U/mg. Assay 2: Fully biologically active when compared to standard. The ED50 as determined by the stimulation of protein synthesis using rat L6 myoblasts is less than 10 ng/mL, corresponding to a specific activity of > 1.0 x 10^5 U/mg.
Especificaciones
| SDS-PAGE, Bioactivity | |
| 3479 | |
| 5 mg | |
| Less than 0.01 EU/μg of IGF-I/IGF-1 AS determined by LAL method. | |
| IGF1 | |
| Biologically Active Proteins, Cell Cycle and Replication, Signal Transduction | |
| IGF-I/IGF-1 |
| Lyophilized from a 0.2 μm filtered concentrated solution in 20 mM PB, pH 7.2. | |
| MolecularWeight-theroretical: 9.1 kDa | |
| Store at -20°C to -70°C as supplied. After reconstitution, store at 2 to 8 C for 1 month and (at -20°C to -70°C for long term storage. Avoid repeated freeze/thaw cycles.) | |
| IBP1, IGF1A, IGFI, IGF-I, IGF-IA, IGF-IB, insulin-like growth factor 1, insulin-like growth factor 1 (somatomedin C), insulin-like growth factor I, insulin-like growth factor IA, insulin-like growth factor IB, Mechano growth factor, MGF, somatomedin-C | |
| Recommended to centrifuge prior to opening. Reconstitute in sterile distilled water or aqueous buffer containing 0.1% BSA to a concentration of 0.1-1.0 mg/mL Apportion stock solutions into working aliquots and store (at <-20°C.) | |
| >98%, by SDS-PAGE |
Corrección del contenido de un producto
Proporcione sus comentarios sobre el contenido del producto rellenando el siguiente formulario.
Título del producto
Novus Biologicals™ Recombinant Human IGF-I/IGF-1 LR3 Protein > 5 mg
¿Detecta una oportunidad de mejora?Comparta una corrección de contenido